ArticleDigital health
Detection of disease on nasal breath sound by new lightweight architecture: Using COVID-19 as an example.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infectious diseases, particularly COVID-19, continue to be a significant global health issue. Although many countries have reduced or stopped large-scale testing measures, the detection of such diseases remains a propriety. Objective: This study aims to develop a novel, lightweight deep neural network for efficient, accurate, and cost-effective detection of COVID-19 using a nasal breathing audio data collected via smartphones. Methodology: Nasal breathing audio from 128 patients diagnosed with the Omicron variant was collected. Mel-Frequency Cepstral Coefficients, a widely used feature in speech and sound analysis, were employed for extracting important characteristics from the audio signals. Additional feature selection was performed using random forest (RF) and principal component analysis (PCA) for dimensionality reduction. A Dense-ReLU-Dropout model was trained with K-fold cross-validation (K = 3), and performance metrics like accuracy, precision, recall, and F1-score were used to evaluate the model. Results: The proposed model achieved 97% accuracy in detecting COVID-19 from nasal breathing sounds, outperforming state-of-the-art methods such as those by Lella and Alphonse and Abayomi-Alli et al. Our Dense-ReLU-Dropout model, using RF and PCA for feature selection, achieves high accuracy with greater computational efficiency compared to existing methods that require more complex models or larger datasets. Conclusion: The findings suggest that the proposed method holds significant potential for clinical implementation, advancing smartphone-based diagnostics in infectious diseases. The Dense-ReLU-Dropout model, combined with innovative feature processing techniques, offers a promising approach for efficient and accurate COVID-19 detection, showcasing the capabilities of mobile device-based diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.